Ionis Pharmaceuticals, Inc.IONSNASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P36
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -18.00% |
| Q4 2025 | -198.30% |
| Q2 2025 | 183.91% |
| Q1 2025 | -15.33% |
| Q4 2024 | -14.18% |
| Q3 2024 | 11.48% |
| Q2 2024 | 9.97% |
| Q1 2024 | -562.14% |
| Q4 2023 | 130.00% |
| Q3 2023 | -1.65% |
| Q2 2023 | 24.21% |
| Q1 2023 | 28.99% |
| Q4 2022 | -551.66% |
| Q3 2022 | -39.34% |
| Q2 2022 | 35.77% |
| Q1 2022 | -117.62% |
| Q4 2021 | 431.87% |
| Q3 2021 | 12.75% |
| Q2 2021 | -19.60% |
| Q1 2021 | -163.29% |
| Q4 2020 | 490.50% |
| Q3 2020 | 57.86% |
| Q2 2020 | -215.12% |
| Q1 2020 | -106.53% |
| Q4 2019 | 979.28% |
| Q3 2019 | 5.59% |
| Q2 2019 | -131.32% |
| Q1 2019 | -8.76% |
| Q4 2018 | 469.17% |
| Q3 2018 | -106.24% |
| Q2 2018 | 4783.85% |
| Q1 2018 | -11.04% |
| Q4 2017 | 3.28% |
| Q3 2017 | 345.91% |
| Q2 2017 | -103.77% |
| Q1 2017 | 497.47% |
| Q4 2016 | -240.72% |
| Q3 2016 | 155.39% |
| Q2 2016 | 50.20% |
| Q1 2016 | -89.08% |